AllianceBernstein’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-131,235
| Closed | -$13.4M | – | 3200 |
|
2023
Q2 | $13.4M | Buy |
131,235
+62,262
| +90% | +$6.35M | 0.01% | 996 |
|
2023
Q1 | $6.27M | Sell |
68,973
-44,366
| -39% | -$4.03M | ﹤0.01% | 1309 |
|
2022
Q4 | $4.31M | Buy |
113,339
+78,439
| +225% | +$2.98M | ﹤0.01% | 1499 |
|
2022
Q3 | $877K | Hold |
34,900
| – | – | ﹤0.01% | 2359 |
|
2022
Q2 | $1.06M | Buy |
34,900
+800
| +2% | +$24.3K | ﹤0.01% | 2308 |
|
2022
Q1 | $1.12M | Buy |
34,100
+100
| +0.3% | +$3.28K | ﹤0.01% | 2374 |
|
2021
Q4 | $897K | Sell |
34,000
-200
| -0.6% | -$5.28K | ﹤0.01% | 2502 |
|
2021
Q3 | $3.44M | Hold |
34,200
| – | – | ﹤0.01% | 1806 |
|
2021
Q2 | $4.84M | Buy |
34,200
+24,931
| +269% | +$3.53M | ﹤0.01% | 1628 |
|
2021
Q1 | $924K | Sell |
9,269
-2,681
| -22% | -$267K | ﹤0.01% | 2432 |
|
2020
Q4 | $1.48M | Sell |
11,950
-100
| -0.8% | -$12.4K | ﹤0.01% | 2130 |
|
2020
Q3 | $1.17M | Buy |
12,050
+650
| +6% | +$63.3K | ﹤0.01% | 2105 |
|
2020
Q2 | $1.78M | Sell |
11,400
-34,830
| -75% | -$5.44M | ﹤0.01% | 1896 |
|
2020
Q1 | $6.67M | Buy |
46,230
+400
| +0.9% | +$57.7K | ﹤0.01% | 1054 |
|
2019
Q4 | $9.37M | Buy |
45,830
+20,030
| +78% | +$4.09M | 0.01% | 1110 |
|
2019
Q3 | $2.07M | Hold |
25,800
| – | – | ﹤0.01% | 1886 |
|
2019
Q2 | $2.43M | Sell |
25,800
-500
| -2% | -$47.2K | ﹤0.01% | 1847 |
|
2019
Q1 | $2.25M | Buy |
26,300
+2,800
| +12% | +$239K | ﹤0.01% | 1823 |
|
2018
Q4 | $1.32M | Sell |
23,500
-100
| -0.4% | -$5.61K | ﹤0.01% | 2060 |
|
2018
Q3 | $1.93M | Buy |
23,600
+5,700
| +32% | +$466K | ﹤0.01% | 1957 |
|
2018
Q2 | $626K | Buy |
17,900
+1,800
| +11% | +$63K | ﹤0.01% | 2521 |
|
2018
Q1 | $330K | Buy |
16,100
+1,900
| +13% | +$38.9K | ﹤0.01% | 2655 |
|
2017
Q4 | $402K | Hold |
14,200
| – | – | ﹤0.01% | 2595 |
|
2017
Q3 | $442K | Hold |
14,200
| – | – | ﹤0.01% | 2603 |
|
2017
Q2 | $449K | Buy |
14,200
+3,200
| +29% | +$101K | ﹤0.01% | 2632 |
|
2017
Q1 | $249K | Hold |
11,000
| – | – | ﹤0.01% | 2763 |
|
2016
Q4 | $240K | Hold |
11,000
| – | – | ﹤0.01% | 2800 |
|
2016
Q3 | $290K | Buy |
+11,000
| New | +$290K | ﹤0.01% | 2696 |
|